Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

Updated April 8th, 2022

Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

A new analysis shows that, among patients with metastatic non-squamous non-small cell lung cancer, the benefits of immunotherapy hold true regardless of the presence of a KRAS mutation.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.